Association between polymorphism of the tumor necrosis factor alpha-308 gene promoter and colon cancer in the Chinese population

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 11, 2011, Pages 743-747

  Li, Mingqi ^a   You, Qi ^a   Wang, Xishan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CHINESE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR GROWTH; TUMOR LOCALIZATION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLONIC NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81755162827     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0068     Document Type: Article

References (45)

1. Abraham LJ, Kroeger KM (1999) Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562-566. (Pubitemid 29489880)
2. Abrahamsson J, Carlsson B, Mellander L (1993) Tumor necrosis factor-alpha in malignant disease. Am J Pediatr Hematol Oncol 15:364-369.
3. Ahirwar DK, Mandhani A, Dharaskar A, et al. (2009) Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy. BJU Int 104:867-873.
4. Azmy IA, Balasubramanian SP, Wilson AG, et al. (2004) Role of tumour necrosis factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res 6:R395-R400.
5. Cao H, Xu Z, Long H, et al. (2010) The-765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis. Tohoku J Exp Med 222:15-21.
6. Fan W, Maoqing W, Wangyang C, et al. (2011) Relationship between the polymorphism of tumor necrosis factor-alpha-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet 19:432-437.
7. Fang F, Yu L, Zhong Y, et al. (2010) TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol 27:1324-1328.
8. Gao Y, Cao Y, Tan A, et al. (2010) Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: an updating meta-analysis and HuGE review of 36 case-control studies. Ann Epidemiol 20:108-121.
9. Garcia FU, Chen HL, Yang Y, et al. (1994) Tumor necrosis factor-alpha mRNA and protein in endometrial tumors: analysis by in situ hybridization and immunocytochemistry. Hum Pathol 25:1324-1331. (Pubitemid 24378740)
10. Garrity-Park MM, Loftus EV Jr., Bryant SC, et al. (2008) Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 103:407-415. (Pubitemid 351248709)
11. Gonzalez S, Rodrigo L, Martinez-Borra J, et al. (2003) TNF-alpha-308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 98:1101-1106. (Pubitemid 36733773)
12. Greene FL (2003) TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 21:23-29. (Pubitemid 37127471)
13. Gunter MJ, Canzian F, Landi S, et al. (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15:1126-1131.
14. Haghighi MM, Taleghani MY, Mohebbi SR, et al. (2010) Impact of EXO1 polymorphism in susceptibility to colorectal cancer. Genet Test Mol Biomarkers 14:649-652.
15. Harwix S, Andreesen R, Ferber E, et al. (1992) Human macro-phages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. Res Immunol 143:89-94.
16. Ho SY, Wang YJ, Chen HL, et al. (2004) Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the-308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15:657-663.
17. Ikeda S, Sasazuki S, Natsukawa S, et al. (2008) Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol 103: 1476-1487. (Pubitemid 351813910)
18. Jang WH, Yang YI, Yea SS, et al. (2001) The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166:41-46. (Pubitemid 32274283)
19. Jin JQ, Hu YY, Niu YM, et al. (2011) CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol 17:260-266.
20. Kang MJ, Jung SA, Jung JM, et al. (2011) Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res 31:575-584.
21. Komori A, Yatsunami J, Suganuma M, et al. (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53:1982-1985. (Pubitemid 23145713)
22. Kroeger KM, Carville KS, Abraham LJ (1997) The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399. (Pubitemid 27368335)
23. Landi S, Moreno V, Gioia-Patricola L, et al. (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxi-some proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63:3560-3566. (Pubitemid 36793036)
24. Lu YL, Li GL, Huang HL, et al. (2010) Peroxisome proliferator-activated receptor-gamma 34C G polymorphism and colo-rectal cancer risk: a meta-analysis. World J Gastroenterol 16: 2170-2175.
25. Macarthur M, Sharp L, Hold GL, et al. (2005) The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 14:1613-1618. (Pubitemid 40995069)
26. Nguyen SP, Bent S, Chen YH, et al. (2009) Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 7:676-681, e671-673.
27. Oh BR, Sasaki M, Perinchery G, et al. (2000) Frequent genotype changes at-308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol 163:1584-1587. (Pubitemid 30226331)
28. Ohyama I, Ohmiya N, Niwa Y, et al. (2004) The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol 16:693-700. (Pubitemid 38901639)
29. Old LJ (1985) Tumor necrosis factor (TNF). Science 230:630-632. (Pubitemid 16190956)
30. Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
31. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, et al. (2000) Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J Med Genet 37:789-792.
32. Rocha AC, Fernandes ES, Quintao NL, et al. (2006) Relevance of tumour necrosis factor-alpha for the inflammatory and noci-ceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol 148:688-695. (Pubitemid 43993059)
33. Sasaki M, Nakajima K, Perinchery G, et al. (2000) Frequent genotype changes at-308 of the human tumor necrosis factor-alpha promoter region in human uterine endometrial cancer. Oncol Rep 7:369-373.
34. Stanczuk GA, Sibanda EN, Tswana SA, et al. (2003) Polymorphism at the-308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer 13:148-153. (Pubitemid 37055469)
35. Stankovic MM, Nestorovic AR, Tomovic AM, et al. (2009) TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma 56:348-352.
36. Sung JJ, Lau JY, Goh KL, et al. (2005) Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6:871-876. (Pubitemid 41614799)
37. Szlosarek PW, Balkwill FR (2003) Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 4:565-573. (Pubitemid 38351714)
38. Theodoropoulos G, Papaconstantinou I, Felekouras E, et al. (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 12:5037-5043. (Pubitemid 44323275)
39. Toth EK, Kocsis J, Madaras B, et al. (2007) The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer 121:1744-1748. (Pubitemid 47417292)
40. Wan H, Zhou Y, Yang P, et al. (2010) Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a meta-analysis. Cancer Epidemiol 34:66-72.
41. Wilson AG, di Giovine FS, Blakemore AI, et al. (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353.
42. Yamamoto H, Hanafusa H, Ouchida M, et al. (2005) Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population. Carcinogenesis 26:411-416. (Pubitemid 40246563)
43. Yang MD, Hsu YM, Kuo YS, et al. (2009) Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res 29: 2239-2242.
44. Zhang L, Zhang G, Wang P, et al. (2011) Association of vascular endothelial growth factor-2578C/A gene polymorphism in Chinese patients with colon cancer. Genet Test Mol Biomarkers 15:117-121.
45. Zhu ZZ, Wang AZ, Jia HR, et al. (2007) Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol 37:385-390.